Company Filing History:
Years Active: 2023
Title: Innovations of Shruti Srivastava in Cancer Therapeutics
Introduction
Shruti Srivastava is a prominent inventor based in Bengaluru, India. She has made significant contributions to the field of biotechnology, particularly in the development of novel therapeutics for cancer treatment. Her work focuses on innovative solutions that address critical health challenges.
Latest Patents
Shruti holds 1 patent for her groundbreaking invention related to antibodies that bind to c-type lectin domain family 2 member d (CLEC2D). The patent details novel anti-CLEC2D antibodies and their related compositions and methods of use. These antibodies are designed for therapeutic applications, as well as prognostic and diagnostic uses in various cancers and other diseases.
Career Highlights
Shruti is currently associated with Zumutor Biologics Inc., where she continues to advance her research and development efforts. Her work at the company emphasizes the importance of innovative approaches in the fight against cancer.
Collaborations
Some of her notable coworkers include Kavitha Iyer Rodrigues and Maloy Ghosh, who contribute to the collaborative environment at Zumutor Biologics Inc. Their combined expertise enhances the potential for impactful discoveries in the field.
Conclusion
Shruti Srivastava's innovative work in developing anti-CLEC2D antibodies showcases her commitment to improving cancer therapeutics. Her contributions are paving the way for advancements in medical science and patient care.